

A practical guide for providers on helping patients locate Endometrin, manage alternatives, and streamline fertility medication access in 2026.
As a fertility provider, you've likely fielded more calls about medication availability than you'd like over the past couple of years. Endometrin (Progesterone vaginal insert, 100 mg) has been among the more challenging fertility medications to source consistently since the late-2023 recall and subsequent shortage.
While supply has improved in 2026, your patients may still encounter pharmacies that are out of stock — especially those using retail chains rather than specialty fertility pharmacies. This guide provides practical steps your practice can take to help patients find Endometrin and maintain uninterrupted luteal phase support.
As of early 2026, the Endometrin supply picture is considerably better than it was in 2024:
For current market conditions, the provider shortage update offers additional detail.
When a patient calls to say their pharmacy doesn't have Endometrin, the issue is usually one of the following:
If your practice doesn't already have established relationships with specialty fertility pharmacies, now is the time. Pharmacies like Freedom Fertility, Encompass Fertility, Village Fertility Pharmacy, and Alto Pharmacy specialize in fertility medications and maintain more reliable Endometrin inventory.
Benefits of specialty pharmacy partnerships:
Medfinder for Providers offers real-time pharmacy availability search for hard-to-find medications, including Endometrin. Your nurse coordinators and pharmacy liaisons can use it to quickly identify which pharmacies in your patients' areas have stock — saving time and reducing patient anxiety.
Consider integrating a Medfinder check into your workflow whenever a patient reports difficulty filling their prescription.
Unless you have a specific clinical reason to require brand-name Endometrin, writing prescriptions that allow generic substitution increases the likelihood of a successful fill. The Xiromed generic Progesterone vaginal insert is AB-rated by the FDA and therapeutically equivalent.
Pharmacies are more likely to have the generic in stock, and it typically costs less for the patient — an important consideration given the financial burden of fertility treatment.
Encourage your team to send Endometrin prescriptions as early as feasible in the treatment cycle. A few extra days of lead time allows pharmacies to order the product if it's not on their shelf, reducing the chance of a last-minute scramble.
For patients with known insurance complications (prior authorization requirements, step therapy), early prescription submission gives time to resolve these issues before the medication is urgently needed.
Include medication availability as a topic in your cycle orientation or patient education materials. Let patients know:
Proactive education reduces panicked phone calls and gives patients a sense of control during an already stressful process.
When Endometrin is unavailable, having pre-established alternative protocols allows quick pivots. Recommended alternatives include:
For a patient-facing comparison, you can direct patients to our guide to Endometrin alternatives.
Based on lessons learned from the shortage, consider implementing these workflow improvements:
The Endometrin shortage underscored the importance of supply chain awareness and clinical flexibility in fertility practice. While the acute shortage has resolved, the operational lessons are worth retaining.
By partnering with specialty pharmacies, allowing generic substitution, sending prescriptions early, and educating patients proactively, your practice can minimize disruptions to treatment cycles and reduce patient stress.
Medfinder for Providers is here to help your team locate hard-to-find medications quickly. And for financial assistance resources to share with patients, see our guide on helping patients save money on Endometrin.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.